Cross-Sector entity
Every one of those 1 sits in a single category, pharma. GSK is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Cross-Sector story that mention University of Kent, all published on March 17, 2026.
1 verified story tracked
Last mentioned: Mar 17, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. GSK is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Cross-Sector story that mention University of Kent, all published on March 17, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering University of Kent. Shared-story counts are live from our verified record — not editorial picks.
Mass Vaccination
UKHSA and NHS begin large-scale immunization drive using the Bexsero vaccine.
Strain Confirmation
Laboratory results confirm Meningitis B as the causative agent; two fatalities reported.
UKHSA Briefing
Health chiefs describe the outbreak as 'explosive' and 'unprecedented' in national alerts.
Initial Reports
First cases of severe meningitis reported among students at the University of Kent.
UK health officials are responding to a severe Meningitis B outbreak at the University of Kent that has left two students dead and 11 others seriously ill. Described as "explosive" and "unprecedented," the cluster has triggered an urgent mass vaccination campaign and heightened surveillance across the region.
